- Home
- SELF vs LUNG Comparison
SELF vs LUNG Comparison
Compare SELF & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SELF
- LUNG
- Stock Information
- Founded
- SELF 1983
- LUNG 1995
- Country
- SELF United States
- LUNG United States
- Employees
- SELF N/A
- LUNG N/A
- Industry
- SELF Real Estate Investment Trusts
- LUNG Industrial Specialties
- Sector
- SELF Real Estate
- LUNG Health Care
- Exchange
- SELF Nasdaq
- LUNG Nasdaq
- Market Cap
- SELF 58.8M
- LUNG 65.6M
- IPO Year
- SELF N/A
- LUNG 2020
- Fundamental
- Price
- SELF $5.01
- LUNG $1.56
- Analyst Decision
- SELF
- LUNG Buy
- Analyst Count
- SELF 0
- LUNG 7
- Target Price
- SELF N/A
- LUNG $7.66
- AVG Volume (30 Days)
- SELF 34.6K
- LUNG 1.0M
- Earning Date
- SELF 08-08-2025
- LUNG 07-30-2025
- Dividend Yield
- SELF 5.79%
- LUNG N/A
- EPS Growth
- SELF 9.99
- LUNG N/A
- EPS
- SELF 0.22
- LUNG N/A
- Revenue
- SELF $12,707,884.00
- LUNG $90,549,000.00
- Revenue This Year
- SELF N/A
- LUNG $17.92
- Revenue Next Year
- SELF N/A
- LUNG $18.56
- P/E Ratio
- SELF $22.78
- LUNG N/A
- Revenue Growth
- SELF 4.08
- LUNG 18.24
- 52 Week Low
- SELF $4.78
- LUNG $1.47
- 52 Week High
- SELF $5.89
- LUNG $9.37
- Technical
- Relative Strength Index (RSI)
- SELF 35.50
- LUNG 30.27
- Support Level
- SELF $5.10
- LUNG $1.47
- Resistance Level
- SELF $5.31
- LUNG $1.63
- Average True Range (ATR)
- SELF 0.13
- LUNG 0.15
- MACD
- SELF -0.01
- LUNG -0.05
- Stochastic Oscillator
- SELF 6.25
- LUNG 4.69
About SELF Global Self Storage Inc.
Global Self Storage Inc is a self-administered and self-managed REIT that owns, operates, manages, acquires, develops, and redevelops self-storage properties. The company's self-storage properties are designed to offer affordable, easily accessible, and secure storage space for residential and commercial customers. It has one segment of Rental operations. Through its wholly-owned subsidiaries, the company owns and/or manages close to thirteen self-storage properties in Connecticut, Illinois, Indiana, New York, Ohio, Pennsylvania, South Carolina, and Oklahoma.
About LUNG Pulmonx Corporation
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.